Home > Clinical Study Management
CLINICAL STUDY MANAGEMENT SERVICES
BioBoston CRO provides clinical study management services through a scoped combination of strategy, planning, vendor evaluation, sponsor-side oversight, independent assessment, expert resourcing, quality review, operational coordination, and partner-supported delivery. The exact model depends on the study, regions, vendors, site network, product, stage, and activities the sponsor needs supported.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
SERVICES
Define the operating model, workstreams, vendors, sites, decision rights, governance, milestones, systems, risks, and resourcing required to execute the study.
Useful before outsourcing, during a major transition, or when the existing model no longer supports the study.
Develop or review feasibility questions, evidence, assumptions, enrollment potential, competing studies, population access, burden, infrastructure, and decision criteria.
Useful when feasibility responses are optimistic, inconsistent, difficult to compare, or not connected to the final protocol.
Support selection criteria, site data review, risk assessment, interview questions, decision documentation, and sponsor approval of the site strategy.
Useful when the sponsor needs independent judgment or a controlled selection process rather than volume-based recommendations.
Plan, assess, coordinate, or oversee startup dependencies such as documents, contracts, budgets, submissions, systems, training, supplies, and activation decisions.
Useful when startup timelines are fragmented across sites, vendors, functions, and countries.
Assess recruitment assumptions, site performance, eligibility barriers, competing studies, outreach models, referral pathways, vendor plans, and recovery options.
Useful as strategy, vendor evaluation, sponsor oversight, independent assessment, or partner-supported delivery after the model is confirmed.
Evaluate participant burden, visit complexity, communication, reimbursement, site practices, missed visits, discontinuations, and retention risks.
Useful when retention threatens data completeness, timelines, or participant experience and the sponsor needs a coordinated response.
Define, review, oversee, resource, or coordinate monitoring responsibilities, plans, visit strategy, reporting, issue escalation, and quality indicators.
Useful when the sponsor needs a confirmed monitoring model, independent oversight, temporary monitoring expertise, or partner-supported execution.
Connect critical data and processes, study risks, key indicators, central review, site activities, thresholds, actions, and documentation in a proportionate monitoring strategy.
Useful when a monitoring plan is overly routine, insufficiently risk-based, or disconnected from quality management.
Plan or review centralized data and operational surveillance, signals, thresholds, trend review, issue triage, site follow-up, and escalation.
Useful when the sponsor needs broader visibility across sites and vendors than visit reports alone provide.
Clarify medical-review scope, safety and eligibility questions, escalation, availability, documentation, and interfaces with investigators, pharmacovigilance, and clinical teams.
Useful as strategy, vendor evaluation, sponsor oversight, expert resourcing, or partner-supported delivery after qualifications and responsibilities are confirmed.
Coordinate or oversee forecasting, packaging and labeling interfaces, release dependencies, depots, shipments, site inventory, returns, excursions, and resupply decisions.
Useful when supply activities must be integrated with enrollment, sites, vendors, protocol changes, and study milestones.
Common Triggers
Desired outcomes
Define what the sponsor, Contract Research Organization, vendors, sites, experts, and partners are expected to decide, perform, review, approve, and escalate.
Create a reviewable view of milestones, sites, recruitment, monitoring, supplies, risks, issues, decisions, and vendor dependencies
Match each activity to the appropriate advisory, oversight, resourcing, direct-delivery, or partner-supported model.
Use documented criteria and evidence for site, vendor, monitoring, recruitment, retention, and recovery decisions.
RELATED SERVICES
Coordinate integrated plans, milestones, budgets, vendors, responsibilities, risks, decisions, and cross functional follow-through.
Document sponsor accountability, oversight plans, risk-based checks, governance evidence, and follow-up for delegated activities.
Manage operational vendor performance, key performance indicators, meeting cadence, issues, delivery, and escalation.
Align data collection, Electronic Data Capture, queries, reconciliations, database lock, and vendor oversight with study operations.
Connect the operating plan to the clinical development roadmap, protocol synopsis, endpoint strategy, vendor selection, and early budget review.
deliverables
Approach
BioBoston CRO first determines what the sponsor needs to decide, oversee, coordinate, assess, resource, or have delivered. The study, countries, sites, vendors, timelines, procedures, systems, risks, and existing responsibilities are then reviewed before the delivery model is selected.
The sponsor remains accountable for study oversight, vendor selection, approvals, regulatory representations, and participant protection. BioBoston should distinguish strategy, sponsor-side oversight, independent assessment, expert resourcing, operational coordination, direct delivery, and partner supported work in every scope and on the public page.
Process
1. Confirm the study phase, regions, sites, vendors, operating model, current responsibilities, milestones, risks, and requested activities.
2. Review the protocol, operational plans, contracts and scopes, site and vendor data, monitoring approach, recruitment assumptions, supply model, and known issues.
3. Define the delivery model and responsibilities for each activity: advisory, oversight, independent assessment, expert-resourced, direct, or partner-supported.
4. Develop the agreed strategy, plans, criteria, governance, oversight tools, resourcing package, or recovery actions.
5. Coordinate implementation, review performance and risks, document decisions, and escalate issues through named sponsor owners.
6. Transition or close the workstream with updated responsibilities, records, actions, metrics, and next-step ownership.
Study-management support is most useful when the sponsor needs clear operational ownership, informed vendor and site decisions, visible risks, and a delivery model matched to the work rather than a broad assumption that one provider performs every activity.
Design the clinical-operations model, select and oversee vendors, and add targeted expertise without building every function internally
Provide sponsor-side strategy, oversight, independent review, issue resolution, or embedded capacity where the primary Contract Research Organization needs direction or support.
Assess feasibility, sites, vendors, monitoring, recruitment, supplies, governance, and responsibilities before implementing a recovery plan.
Expertise
The expert or team assigned to each project is selected based on the specific needs of the program, including study phase and design, geographic scope, site and vendor structure, operational challenges, development stage, therapeutic or product area, endpoints, data requirements, regulatory environment, and key milestones.
Relevant experience is presented through approved expert profiles, giving sponsors clear visibility into the qualifications and background of the professionals supporting their program.
PRACTICAL GUIDANCE
A planned checklist for sponsors, Contract Research Organizations, vendors, sites, responsibilities, governance, systems, risks, and resourcing.
A planned guide to evidence, population access, enrollment assumptions, burden, competition, infrastructure, risk, and decision records..
A planned resource comparing on-site, remote, central, and risk-based activities, responsibilities, indicators, thresholds, and escalation.
FAQs
No. The approved strategy requires the delivery model to be confirmed for each engagement. Depending on the need, support may be advisory, sponsor-side oversight, independent assessment, expert resourcing, quality review, operational coordination, directly delivered, or partner-supported.
Yes. Sponsor-side strategy, oversight, independent assessment, targeted resourcing, quality review, issue resolution, vendor governance, or recovery support may complement a primary Contract Research Organization without duplicating its responsibilities.
Yes. Support may include feasibility strategy, questionnaires, data review, criteria, risk assessment,
interviews, decision documentation, and sponsor oversight. The exact execution model should be
confirmed during scoping.
These capabilities may be considered through expert resourcing, sponsor-side oversight, independent
review, direct delivery, or partner-supported delivery, but qualifications, availability, regions, systems,
procedures, and responsibilities must be confirmed before the public page or proposal states the model.
Clinical Study Management focuses on clinical-operations activities, sites, monitoring, recruitment,
retention, medical oversight, supplies, and execution models. Project Management owns integrated plans, timelines, budgets, vendors, responsibilities, issues, decisions, and cross-functional coordination.
Useful inputs include the protocol and study phase, regions and sites, vendors and contracts, operating plans, current responsibilities, systems, milestones, performance data, known risks and issues, procedures, and the activities BioBoston is expected to support.
PROJECT FORM
Share the study phase, countries and sites, current vendors, operational challenges, target milestone, and the activities that need support. A BioBoston CRO team member will review the delivery model and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the study, regions, sites, vendors, responsibilities, operating challenges, and next milestone. BioBoston can then determine the appropriate strategy, oversight, assessment, resourcing, coordination, direct-delivery, or partner-supported model.
